2.1.8 Provisions and Contingent Liabilities
Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event for which a reliable estimate can be made of the amount of obligation and it is probable that the Company will be required to settle the obligation. When a provision is measured using cash flows estimated to settle the present obligation its carrying amount is the present value of those cash flows; unless the effect of time value of money is immaterial.
Contingent liabilities are disclosed when the Company has a possible obligation from past events, the existence of which will be confirmed only by occurrence or non occurrence of one or more uncertain future events not wholly within the control of the Company or a present obligation that arises from past events where it is either not probable that an outflow of resources will be required to settle or a reliable estimate of the amount cannot be made.
Material contingent liabilities are disclosed in the financial statements unless the possibility of an outflow of economic resources is remote.
2.1.9 Employee benefits
Post-employment obligations
The Company operates the following post¬ employment schemes:
(a) defined benefit plans such as gratuity, and
(b) defined contribution plans such as provident fund
Define benefit plans - Gratuity obligations
The Company provides for gratuity, a defined benefit plan (the “Gratuity Plan") covering eligible employees in India accordance with the Payment of Gratuity Act, 1972 of India. The Gratuity Plan provides a lump sum payment to vested employees at retirement, death, incapacitation or termination of employment, of an amount based on the respective employee’s salary and the tenure of employment.
The liability recognised in the balance sheet in respect of defined benefit gratuity plans is the present value of the defined benefit obligation at the end of the reporting period. The defined benefit obligation is calculated annually by actuary using the projected unit credit method. The present value of the defined benefit obligation is determined by discounting the estimated future cash outflows by reference to yields on government securities at the end of the reporting period that have terms approximating to the terms of the related obligation.
The net interest cost is calculated by applying the discount rate to the balance of the defined benefit obligation. This cost is included in employee benefit expense in the statement of profit and loss.
Remeasurement gains and losses arising from experience adjustments and changes in actuarial assumptions are recognised in the period in which they occur, directly in other comprehensive income. They are included in retained earnings in the statement of changes in equity and in the balance sheet. Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognised immediately in profit or loss as past service cost.
Defined contribution plans Provident fund
Contribution towards provident fund for employees is made to the regulatory authorities, where the Company has no further obligations. Such contribution to the provident fund for all employees, are charged to the profit or loss. Such benefits are classified as Defined Contribution Schemes as the Company does not carry any further obligations, apart from the contributions made on a monthly basis. Such contribution to the provident fund for all employees, are charged to the statement of profit and loss as incurred.
Short term obligations
Liabilities for salaries, including non-monetary benefits that are expected to be settled wholly within 12 months after the end of the period in which the employees render the related service are recognised at the amounts expected to be paid when the liabilities are settled. Short term employee benefits are recognised in statement of profit and loss in the period in which the related service is rendered. The liabilities are presented as employee benefit payable in the balance sheet.
2.1.10 Share based compensation
The company operates shared based compensation plans that provide for the grant of stock-based awards to its officers and employees, including that of its subsidiary. A stock option gives an employee, the right to purchase common stock of the company at a fixed price for a specific period of time.
The fair value of all options granted is recognised as an employee benefits expense with a corresponding increase in equity. The total amount to be expensed is determined by reference to the fair value of the options granted.
The total expense is recognised over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied. At the end of each period, the entity revises its estimates of the number of options that are expected to vest based on the non-market vesting and service conditions. It recognises the impact of the revision to original estimates, if any, in profit or loss, with a corresponding adjustment to equity.
2.1.11 Rounding of amounts
All amounts disclosed in the financial statements and notes have been rounded off to the nearest Millions as per the requirement of Schedule III, unless otherwise stated.
2.1.12 Exceptional items
An item of income or expenses, pertaining to the ordinary activities of the Company, is classified as an exceptional item, when the size, type or incidence of the item merits separate disclosure in order to provide better understanding of the performance of the Company. Accordingly the same is disclosed in the notes accompanying the financial statements.
2.2 Summary of other accounting policies
This note provides a list of other accounting policies adopted in the preparation of these financial statements. These policies have been consistently applied to all the periods presented, unless otherwise stated.
2.2.1 Financialassetsand financial liabilities - subsequent measurement
Trade payables
These amounts represent liabilities for goods and services provided to the entity prior to the end of financial year which is unpaid. Trade payables are presented as current liabilities unless payment is not due within 12 months after the reporting period. They are recognised initially at the fair value and subsequently measured at amortised cost using the effective interest method.
2.2.2 Contributed Equity
Equity shares are classified as equity.
Incremental costs directly attributable to the issue or re-purchase of equity shares, net of any tax effects, are recognised as a deduction from equity.
2.2.3 Dividends
Provision is made for the amount of any dividend declared, being appropriately authorised and no longer at the discretion of the entity, on or before the end of the reporting period but not distributed at the end of the reporting period.
2.2.4 Earning per share
Basic Earnings per Share
Basic earnings per share is calculated by dividing:
• the profit attributable to owners of the Company
• by the weighted average number of equity shares outstanding during the financial year, adjusted for bonus elements in equity shares issued during the year.
on the principal amount outstanding. For investments in equity instruments that are not held for trading, the Company’s management has made an irrevocable election to present fair value gains and losses on equity investments in other comprehensive income. In such cases, there is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.
(iii) Financial assets at fair value through profit or loss
Financial assets are measured at fair value through profit or loss unless it is measured at amortised cost or at fair value through other comprehensive income. The transaction costs directly attributable to the acquisition of financial assets and liabilities at fair value through profit and loss are immediately recognised in statement of profit and loss.
(iv) Cash and cash equivalents
The Company considers all highly liquid financial instruments, which are readily convertible into known amounts of cash that are subject to an insignificant risk of change in value and having original maturities of three months or less from the date of purchase, to be cash equivalents. Cash and cash equivalents consist of balances with banks which are unrestricted for withdrawal and usage. For the purposes of the statement of cash flow, cash and cash equivalents is net of outstanding working capital loan which are integral part of cash management activities. In the balance sheet, working capital loans are shown within borrowings in current liabilities.
Remittance in transit includes the money received from customers in USD and temporarily held in the Nostro account with the bank. The amount is credited to the Company’s bank account on submission of relevant documents, which is generally completed within 5 to 6 days.
(v) Trade receivables
Trade receivables are amounts due from customers for goods sold or services performed in the ordinary course of business. Trade receivables are recognised initially at the amount of consideration that is unconditional unless they contain significant financing components, when they are recognised at fair value. The entity holds the trade receivables with the objective to collect the contractual cash flows and therefore measures them subsequently at amortised cost using the effective interest method, less loss allowance.
(vi) Financial liabilities
Subsequent to initial recognition, these liabilities are measured at amortised cost using the effective interest method.
Diluted Earnings per Share
Diluted earnings per share adjusts the figures used in the determination of basic earnings per share to take into account:
• the after tax effect of interest and other financing costs associated with dilutive potential equity shares, and
• the weighted average number of additional equity shares that would have been outstanding assuming the conversion of all dilutive potential equity shares or options.
2.2.5 Statement of Cash Flows
Cash flows are reported using the indirect method, whereby the profit before tax is adjusted for the effects of transactions of a non-cash nature, any deferrals or accruals of past or future operating cash receipts or payments and item of income or expenses associated with investing or financing cash flows. The cash flows from operating, investing and financing activities of the Company are segregated. For the purposes of the statement of cash flow, cash and cash equivalents is net of outstanding bank overdrafts which are integral part of cash management activities. In the balance sheet, bank overdrafts are shown within borrowings in current liabilities.
2.2.6 Non derivative financial instruments
Financial assets and liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument. Financial assets and liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value measured on initial recognition of financial asset or financial liability.
A Financial assets and financial liabilities - subsequent measurement
(i) Financial assets at amortised cost
Financial assets are subsequently measured at amortised cost if these financial assets are held within a business whose objective is to hold these assets in order to collect contractual cash flows and the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.
(ii) Financial assets at fair value through other comprehensive income
Financial assets are measured at fair value through other comprehensive income if these financial assets are held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets and the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest
B Derecognition of financial assets
A financial asset is derecognised only when:
a) the entity has transferred the rights to receive cash flows from the financial assets or
b) retains the contractual right to receive the cash flows of the financial asset, but assumes a contractual obligation to pay the cash flows to one or more recipients.
Where the entity has transferred an asset, the entity evaluates whether it has transferred substantially all risks and rewards of ownership of financial assets. In such cases, financial asset is derecognised.
C Derecognition of financial liabilities
A financial liability is derecognised when the obligation under the liability is discharged or cancelled or expires. When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is recognised in the statement of profit or loss.
D Income recognition Interest income
Interest income from financial assets at amortised cost is calculated using the effective interest method is recognised in the statement of profit and loss as part of other income.
Dividends
Dividends are recognised as other income in profit or loss, when the right to receive payment is established.
2.2.7 Impairment
Financial assets (other than at fair value)
The entity assesses on a forward looking basis the expected credit losses associated with its assets carried at amortised cost. The impairment methodology applied depends on whether there has been a significant increase in credit risk. The Company applies simplified approach which requires lifetime expected loses for all the contracts assets and/or all trade receivables to be recognised from initial recognition of the receivable. For all other financial assets, expected credit losses are measured at an amount equal to the 12-month expected credit losses or at an amount equal to the life time expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition.
2.2.8 Property, plant and equipment
Property, plant and equipment (“PPE") are stated at cost of acquisition less accumulated depreciation and impairment loss, if any. Cost comprises of the purchase price including import duties and non-refundable taxes and directly
attributable expenses incurred to bring the asset to the location and condition necessary for it to be capable of being operated in the manner intended by management.
Subsequent costs are included in the asset’s carrying amount or recognised as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of any component accounted for as a separate asset is derecognised when replaced. All other repairs and maintenance are charged to profit or loss during the reporting period in which they are incurred.
2.2.9 Intangible assets
a) Acquired Intangible Assets
Intangible assets with finite useful lives that are acquired are initially recognised at cost in case of separately acquired assets and at fair value in case of acquisition in business combination. Subsequent to initial recognition, intangible assets are reported at cost less accumulated amortisation and impairment loss, if any. Amortisation is recognised on a straight-line basis over their estimated useful lives.
Amortisation method, estimated useful lives and residual values are reviewed at the end of each year and adjusted prospectively where appropriate.
An intangible asset is derecognised on disposal or when no future economic benefits are expected to arise from the continued use of the assets. Any gain or loss arising on derecognition is determined as the difference between the sales proceeds and the carrying amount of the assets and is recognised in profit or loss.
b) Internally Developed Intangible Assets - Computer Software
Development costs that are directly attributable to the design and testing of identifiable and unique software products controlled by the Company are recognised as intangible assets when the following criteria are met:
a) it is technically feasible to complete the software so that it will be available for use
b) management intends to complete the software and use or sell it
c) there is ability to use or sell the software
d) it can be demonstrated how the software will generate probable future economic benefits
e) adequate technical, financial and other resources to complete the development and to use or sell the software are available, and
f) the expenditure attributable to the software during its development can be reliably measured.
Directly attributable costs that are capitalised of the software include employee costs and an appropriate portion of relevant overheads.
Capitalised development costs are recorded as intangible assets and amortised from the point at which the asset is available for use.
c) Research and Development Costs
Research and development expenditure that do not meet the criteria in (b) above are recognised as an expenses as incurred. Development costs previously recognised as an expense are not recognised as an asset in a subsequent period.
2.2.10 Borrowings
Borrowings are initially recognised at fair value, net of transaction costs incurred. Borrowings are subsequently measured at amortised cost. Any difference between the proceeds (net of transaction costs) and the redemption amount is recognised in profit or loss over the period of the borrowings using the effective interest method. Fees paid on the establishment of loan facilities are recognised as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down.
2.2.11 Finance Cost
Borrowing costs include exchange differences arising from foreign currency borrowings to the extent they are regarded as an adjustment to the interest cost.All borrowing costs are charged to the Statement of Profit and Loss for the period for which they are incurred.
2.2.12 Derivatives and hedging activities
Derivatives are only used for economic hedging purposes and not as a speculative instruments. They are presented as current assets or liabilities to the extent they are expected to be settled within 12 months after the end of the reporting period.
Derivatives are initially recognised at fair value on date a derivative contract is entered into and are subsequently re¬ measured to their fair value at the end of each reporting period. The accounting for subsequent changes in fair value depends on whether the derivative is designated as a hedging instrument, and if so, the nature of the item being hedged.
The Company designates certain derivatives as hedges of a particular risk associated with the cash flows of highly probable forecast transactions (cash flow hedges).
The Company documents at the inception of the transaction the relationship between hedging instruments and hedged items, as well as its risk management objectives and strategy for undertaking various hedging transactions. The Company also documents the nature of the risk being hedged and how
the Company will assess whether the hedging relationship meets the hedge effectiveness requirements (including its analysis of the sources of hedge ineffectiveness and how it determines the hedge ratio).
The full fair value of a hedging derivative is classified as a non-current asset or liability when the remaining maturity of the hedged item is more than 12 months; it is classified as a current asset or liability when the remaining maturity of the hedged item is less than 12 months.
The Company uses forward contracts to hedge forecast transactions. The Company designates the full fair value of the forward contract as the hedging instrument.
Cash flow hedges that qualify for hedge accounting
The effective portion of changes in the fair value of derivatives that are designated and qualify as cash flow hedges is recognised in other comprehensive income and accumulated under the heading cash flow hedging reserve. The gain or loss relating to the ineffective portion is recognised immediately in the profit or loss, and is included within other expenses or other income.
Amounts previously recognised in other comprehensive income and accumulated in equity are reclassified to the profit or loss in the periods when the hedged item affects the statement of profit and loss, in the same line as the recognised hedged item.
Hedge accounting is discontinued when the hedging instrument expires, or is sold or terminated, or when a hedge no longer meets the criteria for hedge accounting. Any gain or loss recognised in other comprehensive income and accumulated in equity at that time remains in equity and is recognised when the forecast transaction is ultimately recognised in the profit or loss. When a forecast transaction is no longer expected to occur, the gain or loss accumulated in equity is recognised immediately in the profit or loss.
2.2.13 Offsetting Financial Instruments
Financial assets and liabilities are offset and the net amount is reported in the balance sheet when there is a legally enforceable right to offset the recognised amounts and there is an intention to settle on a net basis, or realise the asset and settle the liability simultaneously. The legally enforceable right must not be contingent on future events and must be enforceable in the normal course of business and in the event of default, insolvency or bankruptcy of the Company or the counterparty.
2.2.14 Employee benefits
Compensated Absences
Accumulated compensated absences, which are expected to be availed or encashed within 12 months from the end of the year are recognised as undiscounted liability at the balance sheet date and treated as short term employee benefits. The obligation towards the same is measured at
the expected cost of accumulating compensated absences as the additional amount expected to be paid as a result of the unused entitlement as at the year end. Material compensated absences which are not expected to occur within twelve months after the end of the period in which the employee renders the related services are recognised as an actuarially determined liability at the present value of the defined benefit obligation at the balance sheet date.
2.2.15 Segment Reporting
Operating segments are reported in a manner consistent with the internal reporting provided to the Chief Operating Decision Maker (“CODM"). The CODM is responsible for allocating resources and assessing performance of the operating segments. Chief executive officer (“"CEO"") is identified as the CODM for the Company. Wherever relevant, the company will aggregate multiple operating segments into a single segment if it aligns with Indian Accounting Standard 108’s core principle, if they share similar economic characteristics and the segments are similar in each of the following respects: services provided, nature of delivery of services, customer types, methods used to provide their services and regulatory environment, ensuring consistency in segment reporting.
The Company operates in one reportable segment i.e. “’’Healthcare””. Refer note 39 for segment information presented.
2.2.16 Foreign currency translation and transactions
Functional and presentation currency
Items included in the financial statements of the Company are measured using the currency of the primary economic environment in which the entity operates (‘the functional currency’). The financial statements are presented in Indian currency (^ or ^ or ^), which is the Company’s functional and presentation currency.
Foreign currency transactions and balances
Foreign currency transactions are translated into the functional currency using the exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities denominated in foreign currencies at the period end exchange rates are recognised in profit or loss. They are deferred in equity if they relate to qualifying cash flow hedges and qualifying net investment hedges or are attributable to part of the net investment in a foreign operation. A monetary item for which settlement is neither planned nor likely to occur in the foreseeable future is considered as a part of the entity’s net investment in that foreign operation.
Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. Translation differences on assets and liabilities carried at fair value
are reported as part of the fair value gain or loss. For example, translation differences on non-monetary assets and liabilities such as equity instruments held at fair value through profit or loss are recognised in profit or loss as part of the fair value gain or loss and translation differences on non-monetary assets such as equity investments classified as at FVOCI are recognised in other comprehensive income.
2.2.17 Critical accounting judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make estimates and assumptions that affect the reported amounts of revenue, expense, assets, liabilities, equity and disclosures relating to contingent liabilities on the date of the financial statements. Actual results could differ from those estimates.
Estimates and underlying assumptions are reviewed on an ongoing basis. Revision to accounting estimates is recognised in the period in which the estimate is revised and in any future period affected.
Key source of estimation uncertainty which may cause material adjustments:
This note provides an overview of the areas that involved a higher degree of judgement or complexity, and of items which are more likely to be materially adjusted due to estimates and assumptions turning out to be different than those originally assessed. The areas involving critical estimates or judgements are:
- Significant judgement on Identification of performance obligation and recognition of revenue
Other estimates and judgements
- Estimation of defined benefit obligation (note 17)
- Recognition of deferred tax assets (note 21)
- Fair value of share-based payments (note 35)
- Fair value of derivatives (note 15)
- Estimation of provision and contingent liability
- Determination of lease term and discount rate (note 3(b))
Estimates and judgements are continually evaluated. They are based on historical experience and other factors, including expectations of future events that may have a financial impact on the Company and that are believed to be reasonable under the circumstances.
(i) The Company has set up a trust for welfare of employees and named Inventurus Employees Welfare Foundation which is controlled by the Company and therefore consolidated in these financial statements. Such trust hold 44,28,309 (March 31, 2024 - 47,70,722) equity shares representing 2.58% (March 31, 2024 - 2.79%) of equity shares in the Company.
(ii) During the year, the Inventurus Employees Welfare Foundation has re-purchased 305,589 shares (March 31,2024 - 4,400 shares) issued to Company’s employees pursuant to a scheme of stock option.
(iii) As part of the acquisition of Aquity Holding Inc. (“Aquity’'), the Company agreed to discharge certain portion of the consideration towards selling shareholders who were also part of the Aquity Management (hereinafter referred to as “Management Equity Holders"), in the form of the Company’s shares to be subscribed by such Management Equity Holders. There are certain restrictions imposed on these shares on account of which these shares has to be repurchased by the Company during the period of restriction and hence these were classified as financial liabilities rather than equity share capital. Over the period of three years from the date of acquisition, these restrictions will be phased out at the end of each year, and shares will be reclassified as share capital once the restrictions are lifted as part of the deal. During the year, the Company got listed on December 19, 2024 and hence the restrictions on the shares were released as part of the acquisition deal. Thus, these shares were subsequently classified as equity shares during the year ended March 31, 2025.
b. Rights, preferences and restrictions attached to shares
Equity Shares: The Company has issued only one class of equity shares with each share representing one vote per share held. In the event of liquidation, the equity shareholders are eligible to receive the remaining assets of the Company after distribution of all preferential amounts, in proportion to their shareholding. None of the holders of equity shares shall be entitled to transfer any of their shares in the Company in contravention of the term contained in the Article of Association or any shareholders agreement.
c. Shares reserved for issue under options
Information relating to Employee Option Plan, including details of options issued, exercised and lapsed during the financial year and options outstanding at the end of the reporting period is set out in note 35.
Nature and purpose of other reserves
Share application money pending allotment
Share application money pending allotment represents amount received from employees who have exercised ESOP for which shares are pending allotment as on Balance Sheet date. The Inventurus Employees Welfare Foundation (Inventurus ESOP Trust) received amounts from the employees on exercise of options during the year, however the shares had not been issued as on Balance Sheet date. The Company has shown the amount received on exercise of these shares as Share application money pending allotment.
Securities premium
Securities premium account comprises of the premium on issue of shares. The reserve is utilised in accordance with the specific provision of the Companies Act, 2013.
Capital Reserve
The Company had a wholly owned subsidiary in Hyderabad, which was incorporated in 2008 and subsequently in the year 2012 merged with the Company. At the time of merger, the net reserves of the subsidiary were transferred to capital reserve.
Share option outstanding account
Share options outstanding account is used to recognise the grant date fair value of option issued to the employees under Employees stock option ownership plan 2008, Employees stock option ownership plan 2013, Employees stock option ownership plan 2019 and Employees stock option ownership plan 2022 as well as the grant date fair value of the option given to the directors under the share warrants issued as described in note 35.
Capital redemption reserve
As per Companies Act, 2013, capital redemption reserve is created when company purchases its own shares out of free reserves or securities premium. A sum equal to the nominal value of the shares so purchased is transferred to capital redemption reserve. The reserve is utilised in accordance with the provisions of section 69 of the Companies Act, 2013.
Cash flow hedging reserve
The cash flow hedging reserve is used to recognise the effective portion of gains or losses on derivatives that are designated and qualified as cash flow hedges, as described in note 40.
Note 17 - Provisions
a) Compensated absences
Provision for Compensated absences is presented as current, since the Company does not have an unconditional right to defer settlement of these obligations. However, based on past experience, the Company does not expect all employees to avail the full amount of accrued leave or require payment for such leave within the next 12 months. Leave obligation not expected to be settled within the next 12 months for the period ended March 31, 2025 and March 31, 2024 amounts to ^38.39 Million and ^40.85 Million respectively.
The Company’s liability is actuarially determined (using the Projected Unit Credit method) by an Independent actuary at the end of each year. Actuarial losses/ gains are recognised in the Statement of Profit and Loss in the year in which they arise.
b) Post employment obligations
Gratuity - Defined benefit plan
The Company complies with the Payment of Gratuity Act, 1972 and computes the amount payable towards gratuity accordingly. Employees who are in continuous service for a period of 5 years are eligible for gratuity. The amount of gratuity payable on retirement/termination is the employees last drawn basic salary per month computed proportionately for 15 days salary multiplied for the number of years of service. The gratuity plan is unfunded. The weighted average duration of defined benefit obligation is Four years (March 31, 2024 - Four years).
Provident fund - Defined contribution plan
The Company has certain defined contribution plans. Contributions are made to provident fund in India for employees as per regulations. The contributions are made to registered provident fund administered by the government. The obligation of the Company is limited to the amount contributed and it has no further contractual nor any constructive obligation. The expense recognised during the year towards defined contribution plan is ^259.17 Million (March 31, 2024- ^218.81 Millions).
Employee state insurance fund - Defined contribution plan
The Company provides for employee state insurance as per the Employee State Insurance Act, 1948. Employees with gross salary below ^21,000 are eligible for state insurance fund. Contributions are made to employee state insurance funds in India for employees as per the regulation. The obligation of the Company is limited to the amount contributed and it has no further contractual nor any constructive obligation. The expense recognised during the year towards defined contribution plan is ^16.18 Millions (March 31, 2024 - ^15.48 Millions).
Company complies with the Payment of Gratuities Act, 1972 and computes the amount payable towards gratuity accordingly. The liability is certified by an actuary as on balance sheet date.
The sensitivity analysis have been determined based on reasonably possible changes of the respective assumptions occurring at the end of reporting period, while holding all other assumptions constant.
The sensitivity analysis presented above may not be representative of the actual change in the defined benefit obligation as it is unlikely that the change in assumption would occur in isolation of one another as some of the assumptions may be correlated.
Furthermore, in presenting the above sensitivity analysis, the present value of the defined benefit obligation has been calculated using the projected unit credit method at the end of the reporting period, which is the same method as applied in calculating the defined benefit obligation as recognised in the balance sheet.
Risk exposure
Through its defined benefit plan, the Company is exposed to a number of risks, the most significant of which are detailed below:
1. Interest rate risk: A fall in the discount rate which is linked to the Government Security will increase the present value of the liability requiring higher provision.
2. Salary Risk: The present value of the defined benefit plan liability is calculated by reference to the future salaries of members. As such, an increase in the salary of the members more than assumed level will increase the plan’s liability.
3. Asset Liability Matching (ALM) Risk: The plan faces the ALM risk as to the matching cash flow. Company has to manage pay-out based on pay as you go basis from own funds.
4. Mortality risk: Since the benefits under the plan is not payable for life time and payable till retirement age only, plan does not have any longevity risk.
Note 30 - Contingent liabilities
(i) The Company has evaluated the Supreme Court Judgment in case of Vivekananda Vidya Mandir And Others Vs The Regional Provident Fund Commissioner (II) West Bengal and the related circular (Circular No. C-I/1(33)2019/Vivekananda Vidya Mandir/284) dated March 20, 2019 issued by the Employees’ Provident Fund Organisation in relation to non-exclusion of certain allowances from the definition of “basic wages" of the relevant employees for the purposes of determining contribution to provident fund under the Employees’ Provident Funds & Miscellaneous Provisions Act, 1952. Based on the assessment of the management, the aforesaid matter is not likely to have significant impact in respect of earlier periods.
(ii) Pending litigations in respect of direct taxes may result in a tax incidence of ^0.23 Millions (March 31, 2024 - ^0.23 Millions). Based on the advice obtained and assessment in favour of the Company in the past on similar matters, management has disclosed the litigated amount as contingent liability.
(iii) Also refer note 32 of the Financial Statements.
(iv) The Company received a tax order for AY 2022-23 dated March 17, 2025 from the jurisdictional Assessing Officer making certain transfer pricing adjustments. The company has filed an appeal against the same with the Commissioner of Income Tax Appeals. The total demand raised is of ^49.10 Million.
Note 32
In the previous years, the Company had received summons from the Directorate of Revenue Intelligence (‘DRI’) alleging that the Company had claimed and availed export benefits under Service export from India scheme (SEIS) in excess of its eligibility. As a result, the Company had deposited ^174.05 Million under protest, additionally paid interest and duty amounting to ^87.26 Million and decided not to claim ^47.81 Million of balance of export benefits, which has been disclosed as an exceptional item of ^309.12 Million in the statement of profit and loss for the year ended March 31, 2023. Further, the Company received a show cause notice dated December 15, 2024 from Office of the Development Commissioner, Seepz Special Economic Zone. The Company filed a response against the notice asking for additional information. The Company is awaiting a response on aforesaid matter.
Note 35 - Share based payments
ESOP scheme 2022 was introduced on April 22, 2022 to align the provisions of the ESOP scheme with SEBI guidelines, to add few additional definitions, to grant Power to the Board/NRC to modify the scheme to the extent not prejudicial to the interest of the employees, to allow additional disclosures to be made in grant letters etc. and subsumes the previous ESOP schemes (The employee stock option plan 2008, 2013, 2019, 2022) run by the Company. There are no changes in the terms of options granted under previous schemes and the same has not been modified and will continue to be guided by the terms mentioned in those respective schemes.
(A) Employee Stock Ownership Plan 2022 (‘the 2022 Plan')
The Board at their meeting held on April 22, 2022 approved the 2022 Plan, for issue of shares / options to key employees of the Company and its subsidiaries. The cumulative aggregate number of equity shares issued by the Company under this plan and existing 2008, 2013 and 2019 Stock Option Plans shall not exceed 2,10,00,000 equity shares (12% of post issuance share capital).
All granted options under the 2022 Plan, will vest and be available to respective employees to exercise into equity shares upon completion of 12 (10% of granted of options), 24 (15% of granted of options), 36 (25% of granted of options) and 48 (50% of granted of options) months. All options vested but not exercised as per the scheme will be forfeited.
Note 37 - Financial risk management
Fair value hierarchy
This section explains the judgements and estimates made in determining the fair values of the financial instruments that are (a) recognised and measured at fair value and (b) measured at amortised cost and for which fair values are disclosed in the financial statements. To provide an indication about the reliability of the inputs used in determining fair value, the Company has classified its financial instruments into the three levels prescribed under the accounting standard. An explanation of each level follows below the table.
The Company’s activities expose it to a variety of financial risks such as market risk, credit risk and liquidity risk. The Company’s overall risk management programme focuses on the unpredictability of financial markets and seeks to minimise potential adverse effects on its financial performance. The Company hedges its exposure to foreign currency risk by entering into forward contracts.
The Company’s board of directors has overall responsibility for the establishment and oversight of the Company’s risk management framework. The board of directors has established the Risk Management Committee, which is responsible for developing and monitoring the Company’s risk management policies. The committee reports to the board of directors on its activities.
The Company’s risk management policies are established to identify and analyse the risks faced by the Company, to set appropriate risk limits and controls and to monitor risks and adherence to limits. Risk management policies and systems are reviewed periodically to reflect changes in market conditions and the Company’s activities. The Company, through its training, standards and procedures, aims to maintain a disciplined and constructive control environment in which all employees understand their roles and obligations.
The board of directors monitor compliance with the Company’s risk management policies and procedures, and reviews the adequacy of the risk management framework in relation to the risks faced by the Company.
(A) Credit Risk
Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from the Company’s trade and other receivables from customers.
Trade receivables
The Company’s accounts receivables are concentrated in the healthcare industry. However, the Company’s clients typically are well-established hospitals, medical facilities or major health system companies with good credit histories. Payments from clients have been received generally within normal time frames for the industry. The management continuously monitors the credit exposure towards the customers outstanding at the end of each reporting period to determine incurred and expected credit losses. Given that the macroeconomic indicators affecting customers of the Company have not undergone any substantial change, the Company expects the historical trend of minimal credit losses to continue.
Level 1: Level 1 hierarchy includes financial instruments measured using quoted prices. This includes mutual funds which are valued using the closing NAV.
Level 2: The fair value of financial instruments that are not traded in an active market (for example over-the counter derivatives) is determined using valuation techniques which maximize the use of observable market data and rely as little as possible on entity-specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is included in level 2.
Level 3: If one or more of the significant inputs is not based on observable market data, the instrument is included in level 3. This is the case for unlisted equity securities.
Valuation technique used to determine fair value
Specific valuation techniques used to value financial instruments include:
For foreign currency forward contracts, fair valuation is done using present value of future cash flows based on the forward exchange rates at the balance sheet date. They are classified as level 2 in the hierarchy due to the inclusion of observable inputs including counterparty credit risk.
The carrying amounts of trade and other receivables & payables, cash and cash equivalents, other bank balances, term deposits, security deposits and other financial liabilities approximate their fair values due to their short term nature, therefore fair value disclosure for the same has not been given.
Cash & cash equivalents and other bank balances
Cash and cash equivalents are maintained with reputable financial institutions only so as to minimize the associated credit risk. The Company believes these assets to be of high quality with negligible credit risk hence no provision for expected credit loss is made.
Other bank balances are held with bank and financial institution counterparties with good credit rating.
Derivatives
The derivatives are entered into with bank and financial institution counterparties with good credit rating.
Other financial assets
Other financial assets are neither past due nor impaired.
The Company is also subject to risk of healthcare sector and geographic concentration as the entire business operation is in the United states.
(B) Liquidity risk
Liquidity risk is the risk that the Company will encounter difficulty in meeting the obligations associated with its financial liabilities that are settled by delivering cash or another financial asset. The Company’s approach to managing liquidity is to ensure, as far as possible, that it will have sufficient liquidity to meet its liabilities when they are due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company’s reputation.
The risk is managed through cash flow forecasts, the optimisation of daily cash management and by ensuring that adequate borrowing facilities are maintained.
(i) Financing arrangements
The Company also has access to following undrawn borrowing facilities at the end of reporting period in nature of bank overdraft facilities.
(C) Market risk
Market risk is the risk that changes in market prices, such as foreign exchange rates, interest rates and equity prices will affect the Company’s income or the value of its holdings of financial instruments. The objective of market risk management is to manage and control market risk exposures within acceptable parameters, while optimising the return.
(i) Interest rate risk
Interest rate risk is a risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company’s income and operating cash flows are substantially independent of changes in market interest rates. The Company’s only significant interest-bearing financial liabilities are lease liabilities which are measured at amortised cost.
(ii) Currency risk
The Company is exposed to currency risk on account of its operations in USA. The functional currency of the Company is Indian Rupee. The exchange rate between the Indian rupee and foreign currencies has changed substantially in recent periods and may continue to fluctuate substantially in the future. Consequently, the Company uses derivative instruments, i.e, foreign exchange forward contracts to mitigate the risk of changes in foreign currency exchange rates in respect of its highly probable forecasted transactions and recognized assets and liabilities.
The Company enters into foreign currency forward contracts which are not intended for trading or speculative purposes but for hedge purposes to establish the amount of reporting currency required or available at the settlement date of certain payables/ receivables.
The Company also enters into derivative contracts in order to hedge and manage its foreign currency exposures towards future export earnings. Such derivatives contracts are entered into by the Company for hedging purposes only, and are accordingly classified as cash flow hedge.
Note 38 - Capital Management (a) Risk Management
The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern in order to provide returns for the shareholder and benefits for other stakeholders.
The Company considers total equity i.e. retained profit, other reserves, share capital, share premium of its balance sheet to be managed as capital. The Company has financing arrangements as described in note 37(B)(i).
The Company will take appropriate steps in order to maintain, or if necessary adjust, its capital structure.
e) All the non-current assets of the Company except investments (wholly owned subsidiary located in USA) are located in India.
Note 40 - Hedge accounting
The Company’s risk management policy is to hedge its estimated net foreign currency exposure in respect of highly probable forecast sales over the following 12 months at any point in time. The Company uses forward exchange contracts to hedge its currency risk. Such contracts are generally designated as cash flow hedges. The fair values of all such derivative financial instruments are recognised as assets or liabilities at the Balance Sheet date.
The forward exchange forward contracts are denominated in the same currency as the highly probable forecast sales, therefore the hedge ratio is 1:1. Most of these contracts have a maturity of 1-12 months from the reporting date. The Company’s policy is for the critical terms of the forward exchange contracts to align with the hedged item.
The Company determines the existence of an economic relationship between the hedging instrument and hedged item based on the currency, amount and timing of their respective cash flows. The Company assesses whether the derivative designated in each hedging relationship is expected to be and has been effective in offsetting changes in the cash flows of the hedged item using the hypothetical derivative method.
Note 42 - Additional regulatory information required by schedule III
(i) Details of benami property held
No proceedings have been initiated on or are pending against the Company for holding benami property under the Benami Transactions (Prohibition) Act, 1988 (45 of 1988) and Rules made thereunder.
(ii) Borrowing facility secured against current assets
The Company has borrowing facility from banks and financial institutions on the basis of security of current assets. The quarterly returns or statements of current assets filed by the Company with banks and financial institutions are in agreement with the books of accounts.
(iii) Wilful defaulter
The Company has never been declared wilful defaulter by any bank or financial institution or other lender.
(iv) Relationship with struck off companies
The Company has no transactions with the companies struck off under Companies Act, 2013 or Companies Act, 1956.
(v) Compliance with number of layers of companies
The company has complied with the number of layers prescribed under the Companies Act, 2013, read with the Companies (Restriction on number of Layers) Rules, 2017.
(vi) Compliance with approved scheme(s) of arrangements
The Company has not entered into any scheme of arrangement which has an accounting impact on current or previous financial year.
(vii) The Company has not advanced or loaned or invested funds (either borrowed funds or share premium or any other sources or kind of funds) to any other person or entity, including foreign entities (“Intermediaries") with the understanding (whether recorded in writing or otherwise) that the Intermediaries shall, whether, directly or indirectly end or invest in other persons / entities identified in any manner whatsoever by or on behalf of the Company (‘Ultimate Beneficiaries’) or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.
The Company has not received any fund from any person(s) or entity(ies), including foreign entities (“Funding Party") with the understanding (whether recorded in writing or otherwise) that the Company shall directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party (Ultimate Beneficiaries); or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.
(viii) Undisclosed income
There is no undisclosed income under the tax assessments under the Income Tax Act, 1961 which needs to be recorded in the books of account of the company.
(ix) Details of crypto currency or virtual currency
The Company has not traded or invested in crypto currency or virtual currency during the current or previous year.
(x) Valuation of property, plant and equipment, intangible asset and investment property
The Company has not revalued its property, plant and equipment (including right-of-use assets) or intangible assets or both during the current or previous year.
Note 44 - Acquisition by Subsidiary
On October 27, 2023 the Company’s wholly owned subsidiary Inventurus Knowledge Solutions Inc acquired 100% of the issued share capital of Aquity Holdings Inc, a Company delivering clinical and financial results to healthcare provider clients through outsourced services. It delivers medical transcription, coding and scribe services. Aquity Holdings Inc has four subsidiaries namely Aquity Solutions LLC, Aquity Solutions India Private Ltd, Aquity Solutions Australia Pty Ltd and Aquity Cananda ULC. Aquity Holdings Inc was acquired for a total consideration of ^16,740.69 Million.
Note 45 - Audit Trail
The Company has used an accounting software for maintaining its books of account which has a feature of recording audit trail (edit log) facility that has operated during the year for all relevant transactions recorded in the software, except for certain information or data recorded in the software. Other than the aforesaid instances of audit trail not enabled/ maintained, the Company did not notice any instance of audit trail feature being tampered with. Further, the audit trail, to the extent maintained in the prior year has been preserved by the Company as per the statutory requirements for record retention.
Note 46
The Company had filed compounding applications with RBI dated 31st July 2024 for (i) the issuance and allotment of partly-paid up equity shares to non-resident individuals, and (ii) non compliances with regards certain regulatory filings issuance of ESOPs to non resident employees for a foreign subsidiary. RBI, through the compounding orders dated January 20, 2025, January 27, 2025 and 4th March 2025 adjudicated on the matter and has levied penalties of ^0.20 Million, ^0.07 Million and ^0.23 Million on the Company respectively. The Company has paid the said penalties and these matters are now closed.
Note 47
During the year ended March 31, 2025, the Company has completed its Initial Public Offer (IPO) of 18,795,510 equity shares of face value of ^1 each at and issue price of ^1,329 per share. The issue comprised of 100% offer for sale aggregating to ^24,979.23 Millions. Pursuant to the IPO, the equity shares of the Company got listed on National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) on December 19, 2024.
As per our report of even date
For Price Waterhouse Chartered Accountants LLP For and on behalf of the Board of Directors of
Firm registration number: 012754N/N-500016 Inventurus Knowledge Solutions Limited
Priyanshu Gundana Berjis Desai Sachin Gupta
Partner Chairman & Non-Executive Director Whole-time Director
Membership no. 109553 DIN - 00153675 DIN - 02239277
Place : Mumbai, India Place : Mumbai, India Place : Mumbai, India
Date: May 15, 2025 Date: May 15, 2025 Date: May 15, 2025
Nithya Balasubramanian Sameer Chavan
Chief Financial Officer Company Secretary
Membership no: F7211
Place : Mumbai, India Place : Mumbai, India
Date: May 15, 2025 Date: May 15, 2025
|